Illumina, Inc.

NASDAQ:ILMN

80.3 (USD) • At close May 13, 2025
Bedrijfsnaam Illumina, Inc.
Symbool ILMN
Munteenheid USD
Prijs 80.3
Beurswaarde 12,708,518,900
Dividendpercentage 0%
52-weken bereik 68.7 - 156.66
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Jacob Thaysen Ph.D.
Website https://www.illumina.com

An error occurred while fetching data.

Over Illumina, Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company

Vergelijkbare Aandelen

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.37 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

509.13 USD

Biogen Inc. logo

Biogen Inc.

BIIB

123.16 USD

DexCom, Inc. logo

DexCom, Inc.

DXCM

84.11 USD

Royalty Pharma plc logo

Royalty Pharma plc

RPRX

32.82 USD

Seagen Inc. logo

Seagen Inc.

SGEN

228.74 USD

Moderna, Inc. logo

Moderna, Inc.

MRNA

25.49 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)